NCT06168942: An ongoing trial by Biosense Webster, Inc.
This trial is ongoing. It must report results 4 years, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06168942 |
|---|---|
| Title | Laminar Left Atrial Appendage Elimination (LAAX) Pivotal IDE Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 21, 2024 |
| Completion date | Dec. 1, 2028 |
| Required reporting date | Dec. 1, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | June 24, 2025 |
| Days late | None |